Vascular laser and intense pulsed light treatment of rosacea-associated telangiectasia and erythema

Cosmetic Dermatology

Volumn 15, Issue 8, 2002, Pages

  Vidimos, Allison T ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IBUPROFEN; ISOTRETINOIN; METRONIDAZOLE; PETROLATUM; XIPAMIDE;

ARTICLE; BEHAVIOR THERAPY; BLISTER; DIET; DISEASE EXACERBATION; EDEMA; ELECTROSURGERY; ENVIRONMENTAL FACTOR; ERYTHEMA; FLUSHING; HUMAN; INTENSE PULSED LIGHT THERAPY; LOW LEVEL LASER THERAPY; PHOTOTHERAPY; POSTOPERATIVE CARE; ROSACEA; SCAR FORMATION; TELANGIECTASIA; TREATMENT OUTCOME;

EID: 29244482260     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Wilkin JK. Flushing reactions: consequences and mechanisms. Ann Intern Med. 1981;95:468-476.
2. Wilkin JK. Rosacea: pathophysiology and treatment. Arch Dermatol. 1994;130:359-362.
3. Wilkin JK. Vasodilator rosacea. Arch Dermatol. 1980;116:598.
4. Sibeng S, Gawkrodger DJ. Rosacea: a study of clinical patterns, blood flow, and the role of the Demodex folliculorum. J Am Acad Dermatol. 1992;26:590-593.
5. Ayres S Jr. Extrafacial rosacea is rare, but does exist. J Am Acad Dermatol. 1987;16:391-392.
6. Wilkin JK. Epigastric rosacea. Arch Dermatol. 1980;116:584.
7. Jansen T, Plewig G. Rosacea: classification and treatment. J Royal Soc Med. 1997;90:144-150.
8. Gratton D. The many faces of rosacea. J Cutan Med Surg. 1998;2:S4-S23.
9. Singer MI. Drug therapy of rosacea: a problem-directed approach. J Cutan Med Surg. 1998;2(suppl 4):S20-S23.
10. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584-587.
11. Grosshans E. Gesichtsdurchblutung und Pathodenese der Gesichts - dermatosen. J Akt Dermatol. 1993;19:342-346.
12. Goldman MP, Weiss RA, Brody HJ, et al. Treatment of facial telangiectasias with sclerotherapy, laser surgery, and/or electrodesiccation: a review. J Dermatol Surg Oncol. 1993;19:899-906.
13. Thibault PK. Copper vapor laser and microsclerotherapy of facial telangiectasias: a patient questionnaire. J Dermatol Surg Oncol. 1994;20:48-54.
14. Arndt KA. Argon laser therapy of small cutaneous vascular lesions. Arch Dermatol. 1982;118:220-224.
15. Apfelberg DB, Maser MR, Lash H, Flores J. Expanded role of the argon laser in plastic surgery. J Dermatol Surg Oncol. 1983;9:145-151.
16. Apfelberg GB. Summary of argon laser usage in plastic surgery. Scand J Plast Reconstr Surg. 1986;20:13-18.
17. Dicken CH. Argon laser treatment of the red nose. J Dermatol Surg Oncol. 1990;16:33-36.
18. Noe JM, Finley J, Rosen S, Arndt KA. Postrhinoplasty (red nose): differential diagnosis and treatment by laser. Plast Reconstr Surg. 1981;67:661-664.
19. Orenstein A, Nelson JS. Treatment of facial vascular lesions with a 100 mu spot 577 nm pulsed continuous wave dye laser. Ann Plast Surg. 1989;23:310-316.
20. Ross M, Watcher MA, Goodman MM. Comparison of the flashlamp pulsed dye laser with the argon tunable dye laser with robotized handpiece for facial telangiectasia. Lasers Surg Med. 1993;13:374-378.
21. Apfelberg GB. Argon pumped tunable dye laser. Ann Plast Surg. 1994;32:394-400.
22. Broska P, Martinho E, Goodman MM. Comparison of the argon tunable dye laser with the flashlamp pulsed dye laser in treatment of facial telangiectasia. J Dermatol Surg Oncol. 1994;20:749-753.
23. Goldberg DJ, Marcus JM. The use of the frequency-doubled Q-switched Nd:YAG laser in the treatment of small cutaneous vascular lesions. Dermatol Surg. 1996;22:841-844.
24. Goldberg DJ, Meine JG. Treatment of facial telangiectasias with the diode pumped frequency doubled Q switched Nd:YAG laser. Dermatol Surg. 1998;24:828-832.
25. McCoy S, Hanna M, Anderson P, et al. An evaluation of the copper-bromide laser for treating telangiectasia. Dermatol Surg. 1996;22:551-557.
26. McCoy SE. Copper bromide laser treatment of facial telangiectasia: results of patients treated over five years. Lasers Surg Med. 1997;21:329-340.
27. Waner M, Dinehart SM, Wilson MB, Flock ST. A comparison of copper vapor and flashlamp pumped dye lasers in the treatment of facial telangiectasia. J Dermatol Surg Oncol. 1993;19:992-998.
28. Dinehart SM, Waner M, Flock S. The copper vapor laser for treatment of cutaneous vascular and pigmented lesions. J Dermatol Surg Oncol. 1993;19:370-375.
29. Neumann RA, Leonhartsberger H, Bohler-Sommeregger K, et al. Results and tissue healing after copper vapour laser (at 578 nm) treatment of port wine stains and telangiectasias. Br J Dermatol. 1993;128:306-312.
30. Thibault PK. A patient's questionnaire evaluation of krypton laser treatment of facial telangiectases: a comparison with the copper vapor laser. J Dermatol Surg. 1997;23:37-41.
31. Lowe NJ, Behr KL. Fitzpatrick R, et al. Flashlamp pumped dye laser for rosacea-associated telangiectasia and erythema. J Dermatol Surg Oncol. 1991;17:522-525.
32. Ruiz-Esparza J, Goldman MP, Fitzpatrick RE, et al. Flash lamp-pumped dye laser treatment of telangiectasia. J Dermatol Surg Oncol. 1993;19:1000-1003.
33. Scheepers JH, Quaba AA. Clinical experience in the treatment of the 'red nose' using the flashlamp-pumped pulsed dye laser (585 nm). Aesthetic Plast Surg. 1994;18:57-60.
34. Clark SM, Lanigan SW, Marks R. Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci. 2002;17:26-33.
35. West TB, Alster TS. Comparison of the long pulse dye (590-595) nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg. 1998;24:221-226.
36. Silver BE, Livshots YL. Preliminary experience with the KTP/532 nm laser in the treatment of facial telangiectasia. Cosmet Dermatol. 1996;9:61-64.
37. Adrian RM, Tanghetti EA. Long pulse 532nm laser treatment of facial telangiectasias. Dermatol Surg. 1998;24:71-74.
38. Hevia O. New laser treatment for facial telangiectasias: a randomized study. Cosmet Dermatol. 1997;10:53-56.
39. Goldberg DJ, Meine JG. A comparison of four frequency-doubled Nd:YAG (532nm) laser systems for treatment of facial telangiectasias. Dermatol Surg. 1999;18:463-467.
40. Raulin C, Weiss RA, Schonermark P. Treatment of essential telangiectasias with an intense-pulse light source: Photoderm VL. Dermatol Surg. 1997;23:941-946.
41. Schroeter CA, Neumann HA. An intense pulsed light source: the Photoderm VL. flashlamp as a new treatment possibility for vascular skin lesions. Dermatol Surg. 1998;24:743-748.
42. Angermeier MC. Treatment of facial vascular lesions with intense pulsed light. J Cutan Laser Ther. 1999;1:95-100.
43. Negishi K, Tezuka Y, Kushichca N, Wakamatsu S. Photorejuve-nation for Asian skin by intense pulsed light. Dermatol Surg. 2001;27:627-631.
44. Zenzie HH, Altshuler GB, Smirnov MZ, Anderson RR. Evaluation of cooling methods for laser dermatology. Lasers Surg Med. 2000;26:130-144.
45. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption by pulsed radiation. Science. 1983;220:524-527.
46. van Gemert MJ, Welch AJ, Pichering JW, et al. Wavelengths for laser treatment of port wine stains and telangiectasias. Lasers Surg Med. 1995;16:147-155.
47. van Gemert MJ, Welch AJ, Amin AP. Is there an optimal laser treatment for port wine stains? Lasers Surg Med. 1986;6:76-83.
48. Dierickx CC, Casparian JM, Vehugopalal V, et al. Thermal relaxation of portwine stain vessels proved in vivo: the need for 1-10 msec laser pulse treatment. J Invest Dermatol. 1995;105:709-714.
49. Dinehart SM, Flock, S, Waner M. Beam profile of the flash-lamp pumped pulse dye laser: support for overlap of exposure spots. Lasers Surg Med. 1994;15:277-280.
50. Jackson BA, Arndt KA, Dover JS. Are all 585 nm pulsed dye lasers equivalent? J Acad Dermatol. 1996;34:1000-1004.
51. Laughlin SA, Dudley DK. Laser therapy in the management of rosacea. J Cutan Med Surg. 1998;2(suppl 4):S24-S29.
52. McDaniel DH. Clinical usefulness of the Hexascan: treatment of cutaneous vascular and melanocytic disorders. J Dermatol Surg Oncol. 1993;19:312-319.
53. Mordon S, Rotteleur G, Brunetaud JM, et al. Rationale for automated scanners in laser treatment of portwine stains. Lasers Surg Med. 1993;13:113-123.
54. Dover JS, Geronemus R, Stern RS, et al. Dye laser treatment of portwine stains: comparison of the continuous wave dye laser with a robotized scanning device and the pulsed dye laser. J Am Acad Dermatol. 1995;32:237-240.